Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-10 | Mr. Roger M. JewettCFO & Director | 2,00k | 781,64 | Achat | 0,39 | 2,11M | 0,09% |
| 2026-05-08 | Mr. Roger M. JewettCFO & Director | 10,00k | 3,94k | Achat | 0,39 | 2,11M | 0,48% |
| 2026-05-01 | Mr. Roger M. JewettCFO & Director | 2,00k | 831,59 | Achat | 0,41 - 0,42 | 2,10M | 0,10% |
| 2026-04-07 | Mr. Roger M. JewettCFO & Director | 20,00k | 6,65k | Achat | 0,33 - 0,34 | 2,06M | 0,98% |
| 2016-03-27 | Dr. James Barton McrobertsIndependent Director | 174,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 450,67k | 62,89% |
| 2026-03-31 | Mr. Michael L. EdwardsDirector | 348,00k | 0,00 | Open Market Derivative Acquisition | - | 1,08M | 47,54% |
| 2026-03-31 | Mr. Raymond MarksDirector | 325,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 325,00k | - |
| 2026-03-31 | Mr. Roger M. JewettCFO & Director | 2,60M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 2,60M | - |
| 2026-01-02 | Dr. James Barton McrobertsIndependent Director | 16,67k | 7,28k | Achat | 0,44 | 1,53M | 1,10% |
| 2025-12-30 | Dr. R. Doyle StultingChief Medical Officer | 23,33k | 10,23k | Achat | 0,44 | 323,33k | 7,78% |
| 2025-12-30 | Mr. Dean E. BurnsPresident, CEO & Director | 23,33k | 10,23k | Achat | 0,44 | 5,42M | 0,43% |
| 2025-12-30 | Mr. Dean E. BurnsPresident, CEO & Director | 23,33k | 0,00 | Open Market Derivative Acquisition | 0,55 | 23,33k | - |
| 2026-01-02 | Dr. Garth T. WebbFounder, Chairman & Chief Scientific Officer | 15,75k | 6,88k | Achat | 0,44 | 43,70M | 0,04% |
| 2025-12-30 | Mr. Michael L. EdwardsDirector | 33,33k | 14,62k | Achat | 0,44 | 458,33k | 7,84% |
| 2026-01-02 | Mr. Roger M. JewettCFO & Director | 25,00k | 10,93k | Achat | 0,44 | 2,04M | 1,24% |
| 2025-10-03 | Mr. Roger M. JewettCFO & Director | 1,75M | 156,72k | Derivative Exercise and Retained Stock | 0,09 | 2,02M | 647,76% |
| 2025-10-03 | Mr. Roger M. JewettCFO & Director | -1,75M | 0,00 | Other Derivative Disposition | - | 0,00 | -100,00% |
| 2025-10-03 | Mr. Roger M. JewettCFO & Director | 1,62M | 145,52k | Derivative Exercise and Retained Stock | 0,09 | 1,89M | 601,46% |
| 2025-07-15 | Mr. Michael L. EdwardsDirector | 50,00k | 12,75k | Achat | 0,26 | 425,00k | 13,33% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.